rs367831290
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_152383.5(DIS3L2):c.419A>G(p.Asp140Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,613,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D140Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_152383.5 missense
Scores
Clinical Significance
Conservation
Publications
- Perlman syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_152383.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DIS3L2 | NM_152383.5 | MANE Select | c.419A>G | p.Asp140Gly | missense | Exon 6 of 21 | NP_689596.4 | ||
| DIS3L2 | NM_001257281.2 | c.419A>G | p.Asp140Gly | missense | Exon 6 of 14 | NP_001244210.1 | |||
| DIS3L2 | NM_001257282.2 | c.419A>G | p.Asp140Gly | missense | Exon 6 of 7 | NP_001244211.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DIS3L2 | ENST00000325385.12 | TSL:5 MANE Select | c.419A>G | p.Asp140Gly | missense | Exon 6 of 21 | ENSP00000315569.7 | ||
| DIS3L2 | ENST00000409401.7 | TSL:1 | c.419A>G | p.Asp140Gly | missense | Exon 6 of 7 | ENSP00000386594.3 | ||
| DIS3L2 | ENST00000390005.9 | TSL:1 | n.419A>G | non_coding_transcript_exon | Exon 6 of 21 | ENSP00000374655.5 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152032Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 249498 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461840Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727220 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152032Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74262 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.419A>G (p.D140G) alteration is located in exon 6 (coding exon 5) of the DIS3L2 gene. This alteration results from a A to G substitution at nucleotide position 419, causing the aspartic acid (D) at amino acid position 140 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Perlman syndrome Uncertain:1
ClinVar contains an entry for this variant (Variation ID: 531912). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions. This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 140 of the DIS3L2 protein (p.Asp140Gly). This variant is present in population databases (rs367831290, gnomAD 0.02%).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at